York Health Economics Consortium’s Post

🌍 Day 2 at ISPOR Europe – let's talk about health economics and HTA! I’m thrilled to be at ISPOR Europe, connecting with experts and exploring the latest insights in health economics and HTA. If you’re here and looking to strengthen your approach to: 👉 Health economic modelling and evaluation 👉 HTA preparation 👉 Reimbursement strategies 👉 Evidence-based value propositions 👉 Market access and pricing strategy ...visit us at booth 1406! Let’s discuss how we can support your goals with insights and expertise. #healtheconomics #HTA #marketaccess #valueproposition #HEOR #ISPOREurope #ISPOR

Did you hear about the promise of Value of Information analysis, a.k.a. VOI, but does it remain a somewhat vague and distant topic? You are not alone! At the ISPOR Europe meeting in Barcelona I spoke to many people who thought the concept of VOI is interesting, but that it sounds quite complex and is not clear how the outcomes of such an analysis can be interpreted and used. To address this, I had a go at explaining the basics of VOI in this issue of Methods Explained based on a discussion with Saskia Knies and Natalia Kunst, two international experts on the topic. With VOI now being included in HTA guidelines, its use and impact is expected to increase. Hopefully, this article will be a useful resource to get started. Happy reading! Link to the Methods Explained article: https://lnkd.in/ebapM_kS Link to the complete Nov/Dec issue of VOS: https://lnkd.in/ebVy6hht ISPOR—The Professional Society for Health Economics and Outcomes Research

How can we shape new perspectives on the societal gains of health investments?    Dr. Maike Schmitt, Senior Health Economics Researcher at WifOR Institute, will chair a session on prevention policy and public investment at the European Health Economics Association Conference 2024 in Vienna, Austria.     Dr. Schmitt will present WifOR’s recently developed Health ROI Assessor. The tool supports policy decision making about effective resource allocation to and within the healthcare sector. The framework was developed by WifOR’s Prof. Dr. Dennis Ostwald, Dr. Malina Müller, Karla Hernandez-Villafuerte, PhD, Dr. Jan Fries and in close collaboration with Prof. Rifat Atun from Harvard University.     Using the example of a German cancer screening program, the Health ROI Assessor shows how investment in prevention translates into value creation within and beyond the Health Economy and further induces Human Capital gains in terms of paid and unpaid work productivity due to better health.       We look forward to discussing with you how research might contribute to a new understanding of health investments as a driver of economic growth, employment, innovation, and, most importantly: better health for all!     To attend the conference register here: https://lnkd.in/gtpFUgdd    For more on WifOR Institute’s Health Economic Research, head to: https://lnkd.in/e3t6sPPz    #EuHEA2024  #HealthForAll  #HealthIsAnInvestment 

New study in #HSR Wiley from Heather Schacht Reisinger PhD et al uses a practical approach to examining the use of Expert Recommendations for Implementing Change (ERIC) strategies by Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) dimensions for rural health innovations using annual reports on a diverse array of initiatives. WHAT IS KNOWN: Implementation science theories, models, and frameworks can support the planning, implementation, evaluation, and sustainment of evidence-based programs and practices. WHAT THIS STUDY ADDS: Content analysis of readily-available organizational documents such as annual reports can be used to examine implementation strategy utilization. CONCLUSION: Combining the dimensions from the RE-AIM framework and the ERIC strategies allows for understanding the use of implementation strategies across each RE-AIM dimension. Read the full article: https://lnkd.in/dSSSAZwJ

At Initiate, we pride ourselves on our extensive experience in conducting evidence generation and bespoke analyses. Our tailored approach generates valuable evidence to support health technology assessments and publications, ensuring robust and impactful outcomes for our clients. We offer a wide portfolio of evidence generation services including systematic literature reviews , estimation of health state utilities, PRO mapping, regression modelling, advisory boards, Delphi panels , surveys and questionnaires. Here we spotlight meta-analyses and their value in providing additional evidence for HTA submissions. To find out more about our evidence generation and health economics services do get in touch! #DataAnalysis #EvidenceGeneration #HTA #Publications #Innovation #metaanalysis

It is my great pleasure to announce yet another highlight of our conference #EUHEA2024, jointly organised by Institut für Höhere Studien (IHS) and WU (Wirtschaftsuniversität Wien): Matthias Wismar from the European Observatory on Health Systems and Policies and Scott Greer from University of Michigan offer a three-hour policy workshop titled ‘Teaming Up: How Health Economics and Health Policy Analysis can Benefit from Each Other’. The workshop is free of charge and is open also to people not registered for the conference. The purpose of this workshop is to facilitate dialogue between health economists and health policy analysts, aligning with this year's conference theme of ‘Opening up perspectives on health economics’. It will be centred around four topics: · Health system governance · Sustainable development goals and co-benefits · Health workforce · European Health Union More information can be found here: https://lnkd.in/dbTtitj9 The workshop is limited to 60 participants, so registration is required. The workshop aims to include people with different degrees of experience and educational/professional backgrounds.

Let the COMPAMED – Düsseldorf / Deutschland begin. In case you are around join us at Booth M29, Hall 8b. Let’s discuss Horizon Europe topics for 2025, innovation management, health economics and regulatory 👍

Mielenkiintoisia ja odotuksia herättäviä uutisia 👇 Suomessa ei kannata tyytyä vain korjaamaan HTA-toiminnan rakenteita (mikä on ensiarvoisen tärkeää) vaan samassa yhteydessä kannattaa pohtia myös menetelmiin liittyviä seikkoja. Menetelmät ja näkökulmat kehittyvät, ja niistä käydään terveystaloustieteen ja taloudellisen arvioinnin alalla varsin vireää tieteellistä keskustelua. "The Health Economics Methods Advisory group (HEMA) is a new, independent group of health technology assessment agencies from the US, England and Canada that will work together to develop recommendations on adopting novel health economic methods to support decision making by health care systems. HEMA will also consider the need for modifications to current methods, the uncertainties in the application of new methods and suggestions for further research."......."According to ICER, HEMA could look at including dynamic efficiency and dynamic pricing in economic models, novel or non-traditional value in cost-effectiveness analysis and the integration of health equity considerations in quantitative analysis and deliberation." https://lnkd.in/dgrPHqrj

Simple explanation of the evidence synthesis work we deliver for clients

And last but not least...(I'm just going to skim over doing a post about myself) there's the unforgettable Mark Larkin (aka Scary Spice) also heading to #ISPOREurope. Now if you know Mark, you’ll know he’s a live wire, brimming with ideas plus the strategy and know-how to make them reality. When he’s not singing his heart out at a company karaoke session, you’ll find that he’s an advisor on a number of multi-stakeholder scientific advisory boards for global digital registries – where he can bring his wealth of experience on the humanistic and economic impacts of diseases and therapies on patients’ lives. Have a research problem that you can’t see a way out of? Talk to Mark and put his many Cambridge degrees to use! He’ll most likely have a couple of ideas and solutions up his sleeve. Mark’s go-to topics at ISPOR are: 👉 syndicated patient registries 👉 global real-world evidence and insights 👉 outcomes research Vitaccess ISPOR—The Professional Society for Health Economics and Outcomes Research